Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2

Genes Chromosomes and Cancer

Volumn 46, Issue 1, 2007, Pages 45-52

  Fransson, Susanne ^a   Martinsson, Tommy ^a   Ejeskär, Katarina ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER STAGING; CASZ1 GENE; CHROMOSOME 1P; CLSTN1 GENE; CTNNBIP1 GENE; GENE DELETION; GENE EXPRESSION PROFILING; GENE LOSS; GENE MAPPING; HUMAN; LZIC GENE; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PEX14 GENE; PGD GENE; PIK3CD GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RERE GENE; SLC2A5 GENE; TNFRSF9 GENE; TUMOR SUPPRESSOR GENE;

CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; NEUROBLASTOMA; RNA, MESSENGER;

EID: 33751098018     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20387     Document Type: Article

References (41)

1. Abel F, Sjoberg RM, Ejeskar K, Krona C, Martinsson T. 2002. Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours. Br J Cancer 86:596-604.
2. Abel F, Sjoberg RM, Krona C, Nilsson S, Martinsson T. 2004. Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors. Int J Oncol 25:1297-1302.
3. Bader SA, Fasching C, Brodeur GM, Stanbridge EJ. 1991. Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 2:245-255.
4. Behrens J. 2005. The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem Soc Trans 33:672-675.
5. Boussaud V, Soler P, Moreau J, Goodwin RG, Hance AJ. 1998. Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-β receptor, and Fas) in human lung. Eur Respir J 12:926-931.
6. Brodeur GM. 2003. Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 3:203-216.
7. Chen YY, Takita J, Chen YZ, Yang HW, Hanada R, Yamamoto K, Hayashi Y. 2003. Genomic structure and mutational analysis of the human KIF1Bα gene located at 1p36.2 in neuroblastoma. Int J Oncol 23:737-744.
8. Clements WK, Kimelman D. 2005. LZIC regulates neuronal survival during zebrafish development. Dev Biol 283:322-334.
9. Edstrom Elder E, Nord B, Carling T, Juhlin C, Backdahl M, Hoog A, Larsson C. 2002. Loss of heterozygosity on the short arm of chromosome 1 in pheochromocytoma and abdominal paraganglioma. World J Surg 26:965-971.
10. Ejeskar K, Abel F, Sjoberg R, Backstrom J, Kogner P, Martinsson T. 2000. Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3→p36.2, but absence of mutations in primary tumors. Cytogenet Cell Genet 89:62-66.
11. Ejeskar K, Krona C, Caren H, Zaibak F, Li L, Martinsson T, Ioannou PA. 2005. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death. BMC Cancer 5:161.
12. Ejeskar K, Sjoberg RM, Abel F, Kogner P, Ambros PF, Martinsson T. 2001. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours. Med Pediatr Oncol 36:61-66.
13. Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE, Brodeur GM. 1989. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: Correlation with N-myc amplification. Proc Natl Acad Sci USA 86:3753-3757.
14. Fransen M, Terlecky SR, Subramani S. 1998. Identification of a human PTS1 receptor docking protein directly required for peroxisomal protein import. Proc Natl Acad Sci USA 95:8087-8092.
15. Frostad B, Martinsson T, Tani E, Falkmer U, Darnfors C, Skoog L, Kogner P. 1999. The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children. Cancer 87:60-68.
16. Gavva NR, Wen SC, Daftari P, Moniwa M, Yang WM, Yang-Feng LP, Seto E, Davie JR, Shen CK. 2002. NAPP2, a peroxisomal membrane protein, is also a transcriptional corepressor. Genomics 79:423-431.
17. Godfried MB, Veenstra M, Valent A, Sluis P, Voute PA, Versteeg R, Caron HN. 2002. Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma. Eur J Cancer 38:1513-1519.
18. Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppers MJ, Malogolowkin M, Shearer P, Thomas PR, Macklis R, Tomlinson G, Huff V, Green DM. 2005. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable histology Wilms tumor: A report from the National Wilms Tumor Study Group. J Clin Oncol 23:7312-7321.
19. Hussein MR, Sun M, Roggero E, Sudilovsky EC, Tuthill RJ, Wood GS, Sudilovsky O. 2002. Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas. Mol Carcinog 34:35-44.
20. Judson H, van Roy N, Strain L, Vandesompele J, Van Gele M, Speleman F, Bonthron DT. 2000. Structure and mutation analysis of the gene encoding DNA fragmentation factor 40 (caspase-activated nuclease), a candidate neuroblastoma tumour suppressor gene. Hum Genet 106:406-413.
21. Kang S, Denley A, Vanhaesebroeck B, Vogt PK. 2006. Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase. Proc Natl Acad Sci USA 103:1289-1294.
22. Katoh M. 2001. Molecular cloning and characterization of LZIC, a novel gene encoding ICAT homologous protein with leucine zipper domain. Int J Mol Med 8:611-615.
23. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. 2002. The human genome browser at UCSC. Genome Res 12:996-1006.
24. Kilic E, Naus NC, van Gils W, Klaver CC, van Til ME, Verbiest MM, Stijnen T, Mooy CM, Paridaens D, Beverloo HB, Luyten GP, de Klein A. 2005. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci 46:2253-2257.
25. Krona C, Ejeskar K, Abel F, Kogner P, Bjelke J, Bjork E, Sjoberg RM, Martinsson T. 2003. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2. Oncogene 22:2343-2351.
26. Liu Z, Yang X, Tan F, Cullion K, Thiele CJ. 2006. Molecular cloning and characterization of human Castor, a novel human gene upregulated during cell differentiation. Biochem Biophys Res Commun 344:834-844.
27. Martinsson T, Sjoberg RM, Hallstensson K, Nordling M, Hedborg F, Kogner P. 1997. Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours. Eur J Cancer 33:1997-2001.
28. Martinsson T, Sjoberg RM, Hedborg F, Kogner P. 1995. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55:5681-5686.
29. Mora J, Cheung NK, Kushrier BH, LaQuaglia MP, Kramer K, Fazzari M, Heller G, Chen L, Gerald WL. 2000. Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p. J Mol Diagn 2:37-46.
30. Ohira M, Kageyama H, Mihara M, Furuta S, Machida T, Shishikura T, Takayasu H, Islam A, Nakamura Y, Takahashi M, Tomioka N, Sakiyama S, Kaneko Y, Toyoda A, Hattori M, Sakaki Y, Ohki M, Horii A, Soeda E, Inazawa J, Seki N, Kuma H, Nozawa I, Nakagawara A. 2000. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Oncogene 19:4302-4307.
31. Osaki M, Oshimura M, Ito H. 2004. PI3K-Akt pathway: Its functions and alterations in human cancer. Apoptosis 9:667-676.
32. Reali C, Curto M, Sogos V, Scintu F, Pauly S, Schwarz H, Gremo F. 2003. Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: Modulation by FGF-2. J Neurosci Res 74:67-73.
33. Samuels Y, Velculescu VE. 2004. Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 3:1221-1224.
34. Tago K, Nakamura T, Nishita M, Hyodo J, Nagai S, Murata Y, Adachi S, Ohwada S, Morishita Y, Shibuya H, Akiyama T. 2000. Inhibition of Wnt signaling by ICAT, a novel β-catenin-interacting protein. Genes Dev 14:1741-1749.
35. Takayama H, Suzuki T, Mugishima H, Fujisawa T, Ookuni M, Schwab M, Gehring M, Nakamura Y, Sugimura T, Terada M, Yokota J. 1992. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Oncogene 7:1185-1189.
36. Tanaka K, Yanoshita R, Konishi M, Oshimura M, Maeda Y, Mori T, Miyaki M. 1993. Suppression of tumourigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region. Oncogene 8:2253-2258.
37. Waerner T, Gardellin P, Pfizenmaier K, Weith A, Kraut N. 2001. Human RERE is localized to nuclear promyelocytic leukemia oncogenic domains and enhances apoptosis. Cell Growth Differ 12:201-210.
38. White PS, Thompson PM, Gotoh T, Okawa ER, Igarashi J, Kok M, Winter C, Gregory SG, Hogarty MD, Maris JM, Brodeur GM. 2005. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma. Oncogene 24:2684-2694.
39. Yang HW, Chen YZ, Piao HY, Takita J, Soeda E, Hayashi Y. 2001a. DNA fragmentation factor 45 (DFF45) gene at 1p36.2 is homozygously deleted and encodes variant transcripts in neuroblastoma cell line. Neoplasia 3:165-169.
40. Yang HW, Chen YZ, Takita J, Soeda E, Piao HY, Hayashi Y. 2001b. Genomic structure and mutational analysis of the human KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2. Oncogene 20:5075-5083.
41. Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, Graf N, Gessler M. 2006. Target genes of the WNT/β-catenin pathway in Wilms tumors. Genes Chromosomes Cancer 45:565-574.